American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Preventing deaths after prison release
Lead: Preventing deaths after prison release
Lead: Preventing deaths after prison release
Tuesday 23rd April 2024
Explore the urgent need for coordinated healthcare post-prison release and other groundbreaking studies in addiction medicine.
7 minutes
Informative
Compassionate
Educational
Hopeful
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
140 (View all)
Do you want to link to this podcast?
Get the buttons here!Preventing Deaths After Prison Release: A Critical Look at Transitional Care
Episode Overview
- High mortality rates among recently released prisoners highlight the need for better transitional care.
- Genetic variants linked to alcohol use affect multiple health domains.
- Higher initial doses of buprenorphine reduce mortality in opioid use disorder treatment.
- Novel nasal swab for naloxone delivery shows promising results.
- State alcohol policies impact homicide rates.
The markedly elevated rate of death in the first week post-release underscores an urgent need for investment in evidence-based, coordinated transitional healthcare
Imagine being released from prison and facing a higher risk of death in your first week of freedom than ever before. That's the alarming reality discussed in this episode of 'This Week in Addiction Medicine' from ASAM. The host, Claire Rasmussen, dives into a study published in The Lancet that examines mortality outcomes for over 1.4 million formerly incarcerated individuals across eight countries.
The findings are stark: the rate of death is significantly elevated in the first week post-release, highlighting an urgent need for coordinated healthcare, including mental health and substance use disorder treatments. You'll hear about the critical need for evidence-based transitional care to support these vulnerable individuals as they re-enter society. But that's not all. This episode also covers a fascinating study in e-biomedicine that explores genetic variants linked to alcohol use.
With a sample size of over 3 million individuals, the study reveals that these genetic markers affect various health domains beyond just alcohol-related behaviours. It's a compelling look at how our genes can influence multiple aspects of our health. Next up is a study from the Journal of Addiction Medicine, which finds that higher initial doses of buprenorphine in opioid use disorder treatment are associated with reduced mortality rates.
This could be a game-changer for how we approach opioid addiction treatment. You'll also hear about a novel nasal swab for naloxone delivery that promises quicker absorption and higher blood concentrations than traditional nasal sprays. This could make life-saving interventions more effective and accessible. Finally, the episode touches on the relationship between state alcohol policies and homicide rates, the efficacy of psychedelics in treating mental disorders, and the risks faced by offspring of parents with alcohol use disorder.
Why should you listen? Because this episode is packed with cutting-edge research and practical insights that could save lives. Whether you're in the medical field, have a loved one struggling with addiction, or are on your own recovery journey, this episode offers valuable information and hope for a healthier future.